Guinea Bissau Halts Controversial US Funded Infant Vaccine Trial
Published 1d ago · Latest report 12h ago · Policy change
Affects Guinea-Bissau and United States · Covered in 2 countries
Guinea-Bissau halted an infant vaccine trial after critics condemned the study design as unethical.
Guinea-Bissau authorities halted a controversial hepatitis vaccine trial for infants funded by the United States. Critics condemned the study as unethical because half of the participating babies would have been denied the vaccine. Public backlash and expert warnings drove the decision to suspend the project.
- The criticismCritics labeled the study unethical and neocolonial due to its design withholding treatment.
- The targetThe study intended to test a hepatitis vaccine on thousands of infants.
Why it matters
Clinical trials involving vulnerable populations in developing nations often face intense scrutiny over medical ethics and equitable access to healthcare. Controversies surrounding experimental designs that withhold standard preventative care from control groups regularly trigger international debate.
How outlets cover it
What outlets agree on
Authorities in Guinea-Bissau stopped a US-funded vaccine trial for babies after experts and critics condemned it for denying vaccines to half the infants.
In this story
Covered by 2 outlets
50% of the sources are Left
Lean ratings via Media Bias/Fact Check, Ad Fontes Media
- Al JazeeraWhy Guinea-Bissau halted a controversial hepatitis vaccine trial for babies12h ago · open ↗
- BBC NewsWhy a US-funded vaccine trial on babies was cancelled in Guinea-Bissau1d ago · open ↗
Similar stories
What people are saying
Opens a search on that site in a new tab. Posts there are not ours and are not checked.
The headline, summary and key points are AI-generated from the sources above.
Comments